Drug intelligence / Profile preview

Sentra AM

Development stage
Unknown
Lead developer
Physician Therapeutics
Administration
Oral
01

Overview

Sentra AM is a **medical food** formulated as a proprietary blend of amino acids (including choline bitartrate, L-glutamic acid, acetyl L-carnitine), cocoa extract (providing theobromine), Ginkgo biloba, hawthorn berry, and dextrose, designed for the dietary management of metabolic processes associated with **fatigue and cognitive disorders**. Its mechanism centers on restoring and maintaining acetylcholine balance to support neurotransmitter synthesis and activity—specifically to improve symptoms of fatigue and cognitive impairment thought to result from altered neurotransmitter metabolism. Its ingredients are considered GRAS (Generally Recognized As Safe) and are present in physiologically routine dietary amounts, but in specific ratios to elicit a clinical effect. Sentra AM does not demonstrate significant pharmacokinetic interaction with conventional pharmaceuticals and must be taken under physician supervision[1][2][5].

Brand names
Sentra AM
Other names
Sentra AM
02

Targets

ADOR (Adenosine receptors)

Beyond the preview

Go deeper on Sentra AM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sentra AM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call